Research & Development Units
Innovation has been a great passion and priority for Panacea
Biotec. Beginning with a initial focus in 1995, Panacea Biotec
has come a long way to establish a cohesive network of five
highly sophisticated ultra modern R&D centers. A team of
over 300
professional and highly talented researchers are committed to
pursue the constant quest for innovation and therapeutic
advancements
The core area of research & development includes Vaccine
Development, Biopharmaceuticals (big molecules), Drug Delivery
projects and Drug Discovery (small molecules), in compliance
with international regulatory standards. The company’s R&D
centers are recognized by the Government’s Ministry of Science
and technology. For carrying out pre-clinical research, the
company has an animal house and facilities for undertaking
in-vitro and in-vivo microbiology, pharmacology, safety,
efficacy and toxicology studies. Invigorative Research &
Development requires investment in time and money. To meet these
commitments, Panacea Biotec has been steadily increasing its
expenditure on innovative research. From initial capital R&D
expenditure of 18.6 million (3% of net turnover) in 1995 to Rs.
567.05 million (6.82% of net turnover) in fiscal 2007 bears
testimony to exhibit its passion for innovation.
The increase in innovation expenditure is in line with its
strategy to use it’s R&D expertise to find novel therapies and
drug delivery systems.
The company has also plans to further strengthen the R&D base
to cater to more profitable and expanding niches in vaccines and
formulations segments, both in domestic as well as international
market.
Our investments in the field of innovation will provide
access to breakthrough technologies, products and service to
promote health.
LAKSH Drug Discovery R&D Centre
The Company’s state – of – the art Research Center for
development of New Chemical Entities (small molecules) at
Mohali, Punjab is spread over 70,000 Sq.ft. of laboratory
Space and employs more than 60 scientists. This R&D Centre
has capabilities to carry out work on different aspects of
drug discovery which include medical chemistry, in vitro and
in vivo biology, analytical & bio-analytical research,
pharmacokinetics and drug metabolism studies. The focus of
research is on development of NCEs for the treatment of
metabolic disorders, CNS and infectious diseases.
SAMPANN Drug Delivery R&D Centre
The ultra modern & well equipped research facility,
“SAMPANN Drug Delivery” R&D Centre at Lalru, Punjab is
spread across 40,000 sq.ft. of laboratory space with
superior infrastructure, specialized machinery, adequate
resources and highly talented scientists to conduct research
in the areas of Pharmaceutical Formulation Technology,
Pharmacology, Analytical Chemistry, Medicinal Chemistry and
Natural Products. The said research facilities also boasts
of an in-house Intellectual Property Right Management
Department and Information Science Department.
SAMPANN Drug Delivery R&D Centre has demonstrated
capabilities in research on ready products and technologies in
numerous drug delivery research areas like Spatial Release
System (Tablet-in-tablet and inlay tablet), Hydrophillic Matrix
System, Topical Transdermal Gel, Injectable System for Water
Insoluble Drug, Gastroretentive system, Self Emulsifying Drug
Delivery System in Softgels, Oromucoadhesive System, Orally
Disintegrating System and Taste Masked Delivery System. One of
the major achievements has been the successful prosecution by
the IPR department leading to the grant of two important drug
delivery based patents in the USA.
The centre is primarily focused on:
Development of value added drug delivery products that
would address unmet medical needs, Increase patient
convenience and compliance, augment the intellectual capital
of the organisation and contribute towards the
organizational business goals.
Ongoing Projects: SAMPANN R&D centre is developing products
based on highly specialized Drug Delivery, Self Nano –
Emulsifying Injectable System, Depot Injectable Preparations,
Pulmonary Drug Delivery and Oral Controlled Release Systems.
Identification and development of lead compounds from plant sources
A number of new lead compounds from plant sources have
been identified and are currently undergoing preclinical
development.
Significant number of projects have been developed and
cleared for commercialization and 12 new provisional patent
applications were filed during the year under the review.
Biopharmaceutical R&D Center
|
The quality, breadth and magnitude of
Biopharmaceutical Research & Development Center
contributions are unrivalled. Situated in New Delhi, the
Center is dedicated to carry out extensive research in
vaccines and biologicals using genetic engineering,
molecular biology, genomics tools, animal cell
culture, fermentation, purification, formulation,
serology and analytical testing techniques.
The Center recognized by the Department of Scientific
and Industrial Research (DSIR) of the Govt. of India has
about 75 scientists working with objectives to: |
|
|
|
- Develop effective and affordable vaccines for
prevention against various epidemic or infectious
diseases for global market
- Develop novel and therapeutic vaccines by
utilizing cutting edge molecular biology and cell
culture based technologies
- Develop therapeutic fully human monoclonal
antibody for treating infectious diseases and
life-style related disorders
- Develop recombinant biosimilar molecules for
various disorders for global market
- Develop novel therapeutic peptides
|
Grand R&D Centre
On truly international standards Panacea Biotec’s 5th R&D
centre “GRAND” is coming up at Navi Mumbai. GRAND while
supporting worldwide R&D activities will reflect Panacea
Biotec’s Leadership in Research & Development in the field
of Cancer, Airway, GI, CNS & CVS diseases.
The GRAND will work at the intersection of Biological
Sciences, Clinical Sciences, Pharmaceutical Sciences to develop
Novel Drug Delivery Systems based products to respond to the
changing needs of medical professional. |
